Corcept

CORT NASDAQ
10.48
+0.28
+2.75%
Closed 16:58 05/23 EDT
Open
10.13
Prev Close
10.20
High
10.52
Low
10.00
Volume
813.51K
Avg Vol (3M)
859.01K
52 Week High
20.00
52 Week Low
9.14
% Turnover
0.71%
Market Cap
1.20B
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Corcept CORT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor. It is conducting two clinical trials of its selective cortisol modulator, CORT125134. One trial is investigating CORT125134 as a treatment for patients with Cushing syndrome. The second trial is investigating the combination of CORT125134 and nab-paclitaxel (Celgene Corporation's Abraxane) to treat patients with solid-tumor cancers.
MORE >

Recently

Name
Price
%Change